With reference to letter dated 03 November 2025, Suraksha Diagnostic has informed that the Board of Directors of the Company, at its meeting held today, on Monday, 10 November 2025, has considered and approved the unaudited (standalone and consolidated) financial results of the Company for the quarter and six months ended 30 September 2025 along with Limited Review Report thereon, issued by the Statutory Auditors of the Company, enclosed as Annexure-1. The meeting of the Board of Directors commenced at 2.30 pm (IST) and concluded at 4.15 pm (IST).
The above information is a part of company’s filings submitted to BSE.
